2m 2m 2m 2m 2m 2m 2m
XILIO THERAP (XLO)
NASDAQ
$8.20+$0.17 (+2.05%)
Price as of Oct 22, 2026 7:30 PM EDT- $52.8MMarket Cap
- -25.81%1-Year Change
- BiotechnologyIndustry
XILIO THERAP (XLO)
$8.20+$0.17 (+2.05%)
XLO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.03 | ||
Change | -$0.40 (-4.74%) | ||
Open | $8.45 | ||
High | $8.48 | ||
Low | $8.00 | ||
Previous Close | $8.43 | ||
Volume | 15,374 | ||
30-Day Average Volume | 11,461 | ||
1-Week Change | -10.98% | ||
1-Month Change | -11.17% | ||
1-Year Change | -25.81% | ||
3-Year Change | -70.43% | ||
5-Year Change | -96.42% | ||
Fundamentals | |||
Shares Outstanding | 6.6M | ||
Total Assets | $154.3M | ||
Market Cap | $52.8M | ||
Enterprise Value | -$83.2M | ||
Period: QTR TTM FY | |||
Revenue | $18.7M | ||
Net Income | -$6.4M | ||
Free Cash Flow | -$18.8M | ||
EBIT | -$6.4M | ||
EBITDA | -$6.0M | ||
Net Working Capital | $111.3M | ||
EPS | -$0.33 | ||
Enterprise Value/EBITDA | 14 | ||
Enterprise Value/Revenue | -4 | ||
P/B | 1 | ||
P/E | -24 | ||
PEG | -1 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 14 | ||
Last Split Date | 03/16/2026 | ||
Earnings & Revenue